Thursday, August 21, 2025
HomeTagsHealthcare

Healthcare

Antengene Announces IND Approval in China for a Phase II Study of Eltanexor (ATG-016) in Patients with High-Risk Myelodysplastic Syndromes

Antengene Corporation Limited, a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer, announced the...

New Study Shows Electronic Tuning Fork (ETF) Improves Diabetic Ulcer Prediction

O'Brien Medical is pleased to announce the publication of a key research study validating the performance of its premier product, the ETF, in the...

Mission Bio Launches First-in-Class Single-Cell Genomics Solid Tumor Solution on Tapestri Platform

Mission Bio, Inc., the pioneer in high-throughput single-cell DNA and multi-omics analysis, launched the Tapestri Solution for Solid Tumor Research. This new end-to-end single-cell...

Glassbeam Signs Phantom Healthcare, Growing International Presence in Data Analytics for Medical Equipment

Glassbeam, Inc., a pioneer in data and predictive analytics for connected medical machines, announced it has signed on Phantom Healthcare, the leading marketer, refurbisher,...

Medical Technologies Leader Cellmyx Announces U.S. Food and Drug Administration (FDA) 510(k) Clearance for intelliFat BOD

Cellmyx, the authority on autologous adipose grafting and transfer, and a leader in medical technologies for orthopedic physicians, pain management and regenerative medicine, announces...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics